Affordable Access

deepdyve-link deepdyve-link
Publisher Website

New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation.

Authors
  • 1
  • 1 Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 921212, USA.
Type
Published Article
Journal
Antimicrobial Agents and Chemotherapy
1098-6596
Publisher
American Society for Microbiology
Publication Date
Volume
53
Issue
12
Pages
5080–5087
Identifiers
DOI: 10.1128/AAC.00759-09
PMID: 19805571
Source
Medline

Abstract

Statistics

Seen <100 times